Keyphrases
3-channel
13%
5-fluorouracil (5-FU)
16%
Acute Abdomen
40%
Acute Pancreatitis
14%
Adenosine Triphosphate
18%
Adenosine Triphosphate Production
26%
Advanced Gastric Cancer
66%
Amrubicin
20%
ATP Release
32%
Baroreception
13%
Blood Pressure
13%
CagA Protein
13%
Calcium Influx
26%
Cell-Associated
13%
Chemotherapy-induced Diarrhea
20%
Chronic Inflammation
13%
Cisplatin
52%
Clear Cell
13%
Clinical Clerkship
13%
Colorectal Cancer
20%
Combination Chemotherapy
15%
Constipation
13%
Crohn's Disease
13%
Cystic Duct
13%
Diarrhea
24%
Differential Diagnosis
23%
Docetaxel
30%
Drug Use
15%
Drug-induced
13%
Duodenal Stenosis
13%
Duodenal Ulcer
26%
Endoscopic Papillectomy
13%
Exocytosis
18%
Extraintestinal Manifestations
13%
Fluoropyrimidine
41%
Gastric Adaptive Relaxation
13%
Gastric Emptying
16%
Gastric Epithelium
26%
Gastric Neuroendocrine Carcinoma
13%
Gastrointestinal
20%
Gastrointestinal Cancer
16%
Gastrointestinal Stromal Tumor
13%
Glucose Clearance
13%
Healing Process
13%
Helicobacter Pylori (H. pylori)
20%
High Molecular Weight
13%
IgA Vasculitis (IgAV)
13%
Inflammatory Bowel Disease
19%
Infliximab
26%
Inhibitory Motor Neurons
14%
Interstitial Lung Disease
13%
Intestinal Epithelium
22%
Intestinal mucosal Injury
15%
Intra-aortic Balloon Occlusion
13%
Ion Channels
14%
Irinotecan
37%
Japanese Patients
13%
Kampo
13%
Kampo Medicine
13%
Keratinocytes
28%
Lupus Erythematosus
13%
Median Progression-free Survival
14%
Medical Knowledge
13%
Medical Skills
13%
Mitomycin C
26%
Monotherapy
20%
National Database
13%
Neuroendocrine Carcinoma
15%
Nitric Oxide Production
13%
Nivolumab
13%
Non-invasive Method
13%
Non-randomized Comparison
13%
Non-steroidal Anti-inflammatory Drugs (NSAIDs)
25%
Nonerosive Reflux Disease
14%
Novel Therapeutic Targets
13%
Older Men
19%
Oral Epithelium
13%
Pancreatitis
16%
Phase II Study
15%
Portal Thrombosis
13%
Practice Guidelines
40%
Primary Care
40%
Protein-losing Enteropathy
20%
Pulmonary Involvement
13%
Recurrent Lesions
13%
Risk Factors
20%
S-1 Plus Cisplatin
28%
Second-line Chemotherapy
27%
Self-assessment Questionnaire
13%
Shakuyakukanzoto
13%
Stomach
27%
Thermosensitive
13%
TJ-68
13%
Transient Receptor Potential Vanilloid 4 (TRPV4)
100%
Transient Receptor Potential vanilloid-3
13%
TRP Channels
27%
Ulcer
33%
Ulcerative Colitis
26%
Vanilloid
27%
Vesicular nucleotide Transporter
14%
Medicine and Dentistry
Abdominal Cancer
26%
Acute Abdomen
40%
Adenocarcinoma
9%
Adenosine Triphosphate
60%
Antihypertensive
13%
Arm
13%
Balloon Occlusion
13%
Bleeding
9%
Blood Pressure
13%
CagA Protein
13%
Calcium Ion
9%
Calcium Transport
26%
Capsule Endoscopy
9%
Cell Transformation
13%
Cholangiocarcinoma
13%
Chronic Inflammation
13%
Clear Cell
13%
Colon Ulcer
13%
Colorectal Carcinoma
10%
Computer Assisted Tomography
10%
Conservative Treatment
13%
Constipation
20%
Cystic Duct
13%
Diarrhea
11%
Differential Diagnosis
21%
Disease Predisposition
8%
DNA Mismatch Repair
13%
Down Syndrome
13%
Drug Use
13%
Duodenal Ulcer Bleeding
13%
Duodenum
14%
Duodenum Stenosis
13%
Duodenum Ulcer
16%
Endoscopic Hemostasis
13%
Endoscopic Papillotomy
13%
Endoscopic Retrograde Cholangiopancreatography
13%
Endoscopic Submucosal Dissection
13%
Endoscopic Ultrasound Guided Fine Needle Biopsy
13%
Endoscopy
25%
Epitope
13%
Exocytosis
17%
Fluoropyrimidine
15%
Gastroesophageal Reflux
9%
Gastrointestinal Epithelium
19%
Gastrointestinal Stromal Tumor
13%
Gastrointestinal Tumor
13%
Helicobacter Pylori
21%
Immunity
16%
Immunoblotting
13%
Infliximab
13%
Interstitial Lung Disease
13%
Intestine Injury
13%
Ion Channel
15%
Irinotecan
13%
Jejunum
13%
Kampo
13%
Keratinocyte
28%
Koji
8%
Laxative
10%
Lung
8%
Lupus Vulgaris
13%
Lymph Node Metastasis
13%
Lymphoma
13%
Magnifying Endoscopy
13%
Medical Student
13%
Messenger RNA
10%
Methylation
10%
Mitomycin
13%
Myenteric Plexus
13%
Neoplasm
18%
Nitric Oxide
14%
Nivolumab
13%
Non Erosive Reflux Disease
13%
Non Invasive Procedure
13%
Nonsteroid Antiinflammatory Agent
15%
Nucleotide Transporter
14%
Pancreatitis
13%
Portal Vein Thrombosis
13%
Prednisolone
8%
Primary Health Care
40%
Proctocolectomy
10%
Protein Losing Enteropathy
20%
Proteinase Activated Receptor 2
13%
Proton-Pump Inhibitor
14%
Pulmonary Infiltrate
8%
Pyoderma gangrenosum
8%
Reflux Esophagitis
13%
Retrospective Study
13%
Salivation
11%
Self-Diagnosis
13%
Soluble Interleukin 2 Receptor
13%
Stomach Emptying
16%
Transitional Cell Carcinoma
13%
Ulcer
35%
Ulcerative Colitis
26%
Vanilloid Receptor
27%
Vanilloid Receptor 3
13%
Vanilloid Receptor 4
80%
Vasodilator Agent
8%
Wound Healing
13%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Cancer
53%
Acute Abdomen
40%
Acute Pancreatitis
16%
Adalimumab
10%
Adenosine Triphosphate
58%
Adverse Event
12%
Amrubicin
16%
Anemia
9%
Anorexia
5%
Antihypertensive
13%
Autoimmune Disease
5%
Binimetinib
5%
CagA
13%
CagA Protein
13%
Calcium Ion
9%
Capecitabine Plus Oxaliplatin
6%
Chemotherapy
47%
Chronic Inflammation
13%
Cisplatin
50%
Clinical Trial
8%
Clodronic Acid
7%
Colorectal Carcinoma
6%
Constipation
23%
Crohn's Disease
13%
Diarrhea
32%
Digestive System Cancer
13%
Disease Predisposition
8%
Diseases
6%
Docetaxel
28%
Down Syndrome
13%
Epitope
6%
Erethism
5%
Escherichia coli
5%
Esophageal Squamous Cell Carcinoma
13%
Febrile Neutropenia
5%
Fluoropyrimidine
41%
Fluorouracil
15%
Gastroesophageal Reflux
5%
Immunoglobulin A
13%
Indometacin
13%
Inflammatory Bowel Disease
19%
Infliximab
26%
Injury
16%
Intestine Injury
13%
Irinotecan
33%
Irritable Colon
6%
Jaundice
6%
Kampo Medicine (Drug)
13%
Knockout Mouse
10%
Koji
13%
Laxative
10%
Liver Metastasis
6%
Lupus Vulgaris
13%
Maximum Tolerated Dose
7%
Mercaptopurine
13%
Messenger RNA
7%
Mitogen Activated Protein Kinase Kinase Inhibitor
6%
Mitomycin
26%
Monotherapy
16%
Nedaplatin
13%
Neuroendocrine Carcinoma
26%
Neutropenia
9%
Nitric Oxide
13%
Non-Steroidal Anti-Inflammatory Drug
10%
Normal Human
8%
Nucleotide Transporter
14%
Overall Survival
13%
Paclitaxel
13%
Pancreatitis
15%
Portal Vein Thrombosis
13%
Progression Free Survival
11%
Protein Losing Gastroenteropathy
13%
Proteinase Activated Receptor 2
13%
Purpura
5%
Ramucirumab
13%
Retina Detachment
6%
Retrospective Study
13%
Second-Line Chemotherapy
23%
Tumor Necrosis Factor
6%
Tumor Necrosis Factor Inhibitor
13%
Ulcerative Colitis
13%
Vanilloid Receptor
14%
Vanilloid Receptor 3
13%
Vanilloid Receptor 4
80%
Vasculitis
13%
Vasodilator Agent
8%
Western Blot
9%
Wild Type Mouse
5%
Wound Healing
13%